BIOMAT Database Logo BIOMAT Database Logo

ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo. 2003

Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
Unitá Didattico Assistenziale Nefrocardiovascolare, Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie Sanitarie, Università degli Studi di Milano-Bicocca 20052, Monza, Italy.

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are involved in tissue remodeling processes. TIMP-1 is the main native inhibitor of MMPs and it contributes to the development of tissue fibrosis. It is known that ANG II plays a fundamental role in vascular remodeling. In this study, we investigated whether ANG II modulates TIMP-1 expression in rat aortic smooth muscle cells. In vitro, ANG II induces TIMP-1 mRNA expression in a dose-dependent manner. The maximal increase in TIMP-1 expression was present after 3 h of ANG II stimulation. The ANG II increase in TIMP-1 expression was mediated by the ANG type 1 receptors because it was blocked by losartan. The increase in TIMP-1 expression was present after the first ANG II treatment, whereas repeated treatments (3 and 5 times) did not modify TIMP-1 expression. In vivo, exogenous ANG II was administered to Sprague-Dawley rats (200 ng. kg(-1). min(-1) sc) for 6 and 25 days. Control rats received physiological saline. After treatment, systolic blood pressure was significantly higher (P < 0.01), whereas plasma renin activity was suppressed (P < 0.01), in ANG II-treated rats. ANG II increased TIMP-1 expression in the aorta of ANG II-treated rats both at the mRNA (P < 0.05) and protein levels as evaluated by Western blotting (P < 0.05) and/or immunohistochemistry. Neither histological modifications at the vascular wall nor differences in collagen content in the tunica media were present in both the ANG II- and saline-treated groups. Our data demonstrate that ANG II increases TIMP-1 expression in rat aortic smooth muscle cells. In vivo, both short- and long-term chronic ANG II treatments increase TIMP-1 expression in the rat aorta. TIMP-1 induction by ANG II in aortic smooth muscle cells occurs in the absence of histological changes at the vascular wall.

UI MeSH Term Description Entries
D007260 Infusion Pumps Fluid propulsion systems driven mechanically, electrically, or osmotically that are used to inject (or infuse) over time agents into a patient or experimental animal; used routinely in hospitals to maintain a patent intravenous line, to administer antineoplastic agents and other drugs in thromboembolism, heart disease, diabetes mellitus (INSULIN INFUSION SYSTEMS is also available), and other disorders. Drug Infusion Systems,Infusion Pump,Infusion Pumps, External,Infusors,Intravenous Drug Delivery System,Intravenous Drug Delivery Systems,Perfusion Pumps,Pumps, Infusion,Drug Infusion System,External Infusion Pump,External Infusion Pumps,Infusion Pump, External,Infusion System, Drug,Infusion Systems, Drug,Infusor,Perfusion Pump,Pump, External Infusion,Pump, Infusion,Pump, Perfusion,Pumps, External Infusion,Pumps, Perfusion,System, Drug Infusion,Systems, Drug Infusion
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
ANG II receptor expression and function during phenotypic modulation of rat aortic smooth muscle cells.
February 1994, The American journal of physiology,
Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation.
July 2001, Proceedings of the National Academy of Sciences of the United States of America,
Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
Vasopressin increases 45Ca2+ influx in rat aortic smooth muscle cells.
October 1987, Biochemical and biophysical research communications,
Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
Proliferative synergy of ANG II and EGF in porcine aortic vascular smooth muscle cells.
August 1993, The American journal of physiology,
Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
17beta-estradiol downregulates angiotensin-II-induced endothelin-1 gene expression in rat aortic smooth muscle cells.
January 2004, Journal of biomedical science,
Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
Vanadate increases cytosolic free calcium in rat aortic smooth muscle cells.
January 1995, Life sciences,
Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
c‑Jun/Ap‑1 is upregulated in an Ang II‑induced abdominal aortic aneurysm formation model and mediates Chop expression in mouse aortic smooth muscle cells.
May 2019, Molecular medicine reports,
Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
Translational regulation of ANG II type 1 receptors in proliferating vascular smooth muscle cells.
January 2006, American journal of physiology. Regulatory, integrative and comparative physiology,
Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells.
May 2005, European journal of pharmacology,
Giovanna Castoldi, and Cira R T Di Gioia, and Federico Pieruzzi, and Cristina D'Orlando, and Willy M M Van De Greef, and Giuseppe Busca, and Giovanni Sperti, and Andrea Stella
Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. Evidence for selective increases in smooth muscle isoactin expression.
January 1991, Circulation research,
Copied contents to your clipboard!